(Report) 2nd Series on EOL (End of life) Care discussion
date : 10/23/2013
Dr. Akiyama elaborated a contextual example of how to design a life for extended life span and how to make a decision for end of life. Dr. Itoh on the other hand, opened “Hana-no-tani Clinic” near the shore of South Bōsō, Chiba prefecture in order to provide medical care that free from the boundaries of out-patient, home care, or hospice. She talked about why clinic like “Hana-no-tani” was needed and how to provide not only medical care but also to deliver life support.
———-
■Date: Oct 8 (Tuesday) 19:00-21:00
■Place: Marunouchi Building Hall&Conference Square (8F MarunouchiBuilding, 2-4-1 Marunouchi, Chiyoda-ku, Tokyo)
■Organized by: Health and Global Policy Institution, NPO
■Points of view: It allows multispectral speakers to exchange their opinions.
■Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (70 invitees)
■Participation fee:1,500Yen
Language: Japanese (No interpretation)
———-
Program
1. The 1st Review of EOL Seminar
2. Life Design and EOL Care of Hyper Aging Society
Speaker:
-Dr. Hiroko Akiyama(Project Proffessor, Executive associate member, Institute of Gerontology, the University of Tokyo)
-Dr. Mami Ito (Director of “Hana-no-tani”Clinic)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 (Syllabary order, Titles omitted)
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/Surgeon
Exhibition date:2013-10-08
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)